Inventor · disambiguated record
Marvin R. Leanna
Also filed as: LEANNA MARVIN R · LEANNA MARVIN ROBERT
11 granted patents·6 pending applications·193 citations·filing 2000–2023
88Inventor score
Top patents by PatentIndex Score
17 records- 0195US6437106B1Process for preparing 6-o-substituted erythromycin derivativesABBOTT LAB·Filed 2000·Granted Aug 20, 2002·161 cites·30 claims
- 0293US9809576B1Synthetic route to anti-viral agentsABBVIE INC·Filed 2015·Granted Nov 7, 2017·14 cites·2 claims
- 0387US8071762B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorGOMTSYAN ARTHUR R·Filed 2008·Granted Dec 6, 2011·5 cites·5 claims
- 0486US10077256B2Synthetic route to anti-viral agentsABBVIE INC·Filed 2017·Granted Sep 18, 2018·2 cites·14 claims
- 0578US7375126B2Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptorABBOTT LAB·Filed 2004·Granted May 20, 2008·9 cites·8 claims
- 0676US2024115724A1Anti-cd71 activatable antibody drug conjugates and methods of use thereofABBVIE INC·Filed 2023·Application pending·0 cites
- 0773US2020095230A1Synthetic route to anti-viral agentsABBVIE INC·Filed 2019·Application pending·0 cites
- 0870US10442792B2Synthetic route to anti-viral agentsABBVIE INC·Filed 2018·Granted Oct 15, 2019·0 cites·30 claims
- 0969US7521439B2Glucocorticoid receptor ligands for the treatment of metabolic disordersKAROBIO AB·Filed 2006·Granted Apr 21, 2009·1 cites·12 claims
- 1064US2019111150A1Anti-cd71 activatable antibody drug conjugates and methods of use thereofABBVIE INC·Filed 2018·Application pending·0 cites
- 1163US2021145978A1Anti-cd71 activatable antibody drug conjugates and methods of use thereofABBVIE INC·Filed 2020·Application pending·0 cites
- 1256US7141559B2Glucocorticoid receptor ligands for the treatment of metabolic disordersKAROBIO AB·Filed 2003·Granted Nov 28, 2006·1 cites·21 claims
- 1354US7847104B2Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype1 (VR1) receptorsABBOTT LAB·Filed 2007·Granted Dec 7, 2010·0 cites·29 claims
- 1450US2019262417A1Antibody drug conjugate (adc) purificationABBVIE INC·Filed 2019·Application pending·0 cites
- 1550US2014286968A1Antibody drug conjugate (adc) purificationABBVIE INC·Filed 2014·Application pending·0 cites
- 1645US8519186B2Process for the preparation of indazolyl ureas that inhibit Vanilloid subtype 1 (VR1) receptorsLUKIN KIRILL A·Filed 2010·Granted Aug 27, 2013·0 cites·2 claims
- 1745US8124129B2Crystalline form of the compound A-348441CINK RUSSELL DREW·Filed 2006·Granted Feb 28, 2012·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →